European Archives - Page 659 of 1303 - European Medical Journal

Sanofi set to slash insulin costs in US

Sanofi is set to cut the pricing of its insulin products in a massive step toward greater access to medicine in the US. Read to find out more.

Genomic Profiling of Breast Cancer: A Multidisciplinary approach in early stage breast cancer treatment decisions

A virtual webinar presentation featuring Dr. Cathy Graham & Dr. William Audeh exploring latest data and impact of MammaPrint®️ and BluePrint®️

EuropaBio launches 'Vision for Europe' campaign

EuropaBio has launched a campaign to further Europe’s biotech innovation, investment and excellence, and revolutionise healthcare’s future. Read to find out more.

Editor's Pick: Pemphigus Vulgaris and Pemphigus Foliaceus: A Single-Centre Comparative Study in Rabat, Morocco

Pemphigus is a group of rare autoimmune blistering diseases affecting the skin and mucous membranes. Pemphigus foliaceus (PF)…

Ultrasound Imaging and Its Applications in Rheumatology

This podcast focuses on the latest evidence supporting the use of ultrasound in diagnosis within rheumatology with a special focus on rheumatoid arthritis.

Prevalence of Atopic Dermatitis in People of Colour

The results of a new literature review indicate that AD prevalence is higher in individuals identifying as Black or African American…

Increased Risk of Breakthrough COVID-19 Infection in Patients with HIV

The risk of breakthrough COVID-19 infection after vaccination is higher in people with HIV when compared to people without HIV.

Never Miss a Beat

In this episode, Jonathan spoke with David Hildick-Smith, the pair discussed all things cardiology, with a key focus on interventional surgery

EMJ Gastroenterology 11 [Supplement 3] 2022 Feature Image

EMJ Gastroenterology 11 [Supplement 3] 2022

The production of TNFα during chronic inflammation leads to organ damage due to excessive inflammation. As the first in a series…

EMJ Gastroenterology 11 [Supplement 3] 2022 Feature Image

Safety of Anti-TNFs in Patients with Immune-Mediated Disease

Up to 10% of the Western population are affected by IMIDs,1 including inflammatory bowel disease (IBD), rheumatoid arthritis (RA)…